Diploma PLC (LON:DPLM – Get Free Report) has received a consensus recommendation of “Moderate Buy” from the eight analysts that are currently covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and six have given a buy recommendation to the company. The average 1 year price target among brokers that have issued ratings on the stock in the last year is GBX 7,400.
DPLM has been the topic of several research analyst reports. Jefferies Financial Group reissued a “hold” rating and issued a GBX 7,000 target price on shares of Diploma in a research report on Friday, May 29th. Royal Bank Of Canada upped their price target on shares of Diploma from GBX 7,300 to GBX 7,400 and gave the stock an “outperform” rating in a research report on Friday, July 17th. JPMorgan Chase & Co. increased their price target on shares of Diploma from GBX 5,760 to GBX 8,250 and gave the stock an “overweight” rating in a research note on Monday, August 24th. Berenberg Bank reiterated a “buy” rating and issued a GBX 9,000 price target on shares of Diploma in a report on Monday, July 20th. Finally, Deutsche Bank Aktiengesellschaft boosted their price objective on shares of Diploma from GBX 6,400 to GBX 7,200 and gave the company a “buy” rating in a research note on Wednesday, May 20th.
Get Our Latest Analysis on DPLM
Insider Activity at Diploma
Diploma Price Performance
DPLM opened at GBX 7,330 on Monday. The company has a debt-to-equity ratio of 47.65, a current ratio of 2.06 and a quick ratio of 0.80. The stock has a market capitalization of £9.83 billion, a price-to-earnings ratio of 52.06, a price-to-earnings-growth ratio of 2.82 and a beta of 0.92. The business has a 50-day moving average of GBX 7,248.83 and a two-hundred day moving average of GBX 6,653.57. Diploma has a 12 month low of GBX 4,970 and a 12 month high of GBX 7,765.
Diploma Company Profile
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Featured Stories
- Five stocks we like better than Diploma
- DLocal Is Testing the Breakout Level That Could Change Its Stock Story
- Strike a Balance Between Growth and Stability With These 3 Names Ready to Rally
- Rubrik’s AI Security Bet Could Power the Next Leg Higher
- Apple’s Foldable iPhone Could Be a Catalyst, But Not a Cure-All
Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.
